Suzanne Angell, Director of Therapeutic Research, joined Casdin Capital in 2012. Suzanne brings over 16 year of business and investment management experience across multiple platforms.
Prior to joining Casdin, Suzanne served as the Chief Operating Officer and Chief Financial Officer of Jungell, Inc., an organic food company. Previously, Suzanne served as a Managing Director and Advisor for Alpine ESD and C. Kenneth Imports, a real estate firm and food-importing company, respectively.
Suzanne began her career as a Research Analyst at Cooper Hill Partners, a healthcare-focused investment firm where she analyzed healthcare investments in life science tools, diagnostics and medical devices.
Suzanne earned a B.A. in English and Biology from Yale University and her Master of Arts in English Literature from Johns Hopkins University.
This person is not in any offices
Casdin Capital
1 followers
Casdin Capital, LLC (“Casdin”) is a New York-based fundamental research investment firm focused on the life sciences and healthcare industry. The firm manages a long short equity fund and makes investments in early stage to late stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management. Casdin started from a position of curiosity, honesty, and passion to gain a deep and thoughtful understanding of opportunities in the life science ecosystem. They commit to finding the highest quality management teams doing the work to create high growth companies. They use data to continually advance their knowledge and we are long term investors. They believe in collaboration and transparency and operate at the forefront of innovation.